Table 2.

Comparison of BCL6 translocation in FL



Our study




Transformation
Not known to transform
US 1994 (Lo Coco et al34 )
France 1994 (Bastard et al27 )
US 1995 (Otsuki et al11 )
BCL6 translocation*  16/41  9/64  2/31   11/80   6/42  
Ratio (%)   39.0   14.1   6.4   13.8   14.3  
P value   .0048   .0020  .0025  .0134 
Methodology
 
LDI-PCR
 
LDI-PCR
 
Southern blot (Sac 4.0§)
 
Southern blot (F372§)
 
Southern blot (F372§)
 


Our study




Transformation
Not known to transform
US 1994 (Lo Coco et al34 )
France 1994 (Bastard et al27 )
US 1995 (Otsuki et al11 )
BCL6 translocation*  16/41  9/64  2/31   11/80   6/42  
Ratio (%)   39.0   14.1   6.4   13.8   14.3  
P value   .0048   .0020  .0025  .0134 
Methodology
 
LDI-PCR
 
LDI-PCR
 
Southern blot (Sac 4.0§)
 
Southern blot (F372§)
 
Southern blot (F372§)
 
*

BCL6 translocation means nongermline-altered PCR amplification by LDI-PCR or rearrangement by Southern blot.

Two cases, which had a point mutation leading to the generation of a restriction site, were excluded from positive cases.

P value of transformation cases versus cases not known to transform, US 1994, France 1994, and US 1995, respectively.

§

Sac 4.0 or F372 was used to detect BCL6 rearrangement as a probe for Southern blot (Figure 2).

Close Modal

or Create an Account

Close Modal
Close Modal